New Jersey Assembly Bill AR29

New Jersey 2026-2027 Regular Session

• Introduced: 1/13/26
• Refer: 1/13/26

Caption

Urges U.S. President and Congress to cease funding gain-of-function research.

Impact

The resolution highlights a growing sentiment among state lawmakers regarding the dangers associated with gain-of-function research, especially in light of the COVID-19 pandemic. The New Jersey Legislature believes that continuing to fund such research may lead to scenarios where engineered pathogens could escape containment or be weaponized, threatening not just national but global health stability. This stance emphasizes the need for federal oversight and reconsideration of funding policies related to potentially hazardous biological research.

Summary

Assembly Resolution AR29 urges the President and Congress of the United States to cease all funding for gain-of-function research involving pathogenic substances and organisms. Gain-of-function research refers to biological studies that modify the genetic makeup of organisms to create new properties or enhance existing ones. While the intended goal of this research is to better understand pathogens and develop preventive vaccines, concerns have been raised about its potential to produce more virulent and communicable viruses, thereby posing a significant risk to public health.

Contention

Notably, concerns surrounding gain-of-function research have intensified due to previously funded projects that involved pandemic pathogens, specifically referencing the theory that the SARS-CoV-2 virus may have been a product of such research. The resolution points to testimonies from key figures in public health, suggesting a potential cover-up regarding the government's involvement in such research. This backdrop creates significant contention, as proponents argue for the cessation of funding to mitigate risks, while critics may argue that such research is essential for future pandemic preparedness.